Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: addendum: /07 continued to progress. dicloxcilllin dicontinued. antibiotics distontinued. glycemic control required multiple adjustments to insulin dosing. current regment patient's controll much improved. d/c to rehab. stable. wounds clean dry and intact. medications on admission: same except for new meds: amidarone quinepate discharge medications: 1. doxycycline hyclate 100 mg capsule sig: one (1) capsule po q12h (every 12 hours). 2. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed. 3. prednisone 1 mg tablet sig: two (2) tablet po bid (2 times a day). 4. gabapentin 400 mg capsule sig: four (4) capsule po bid (2 times a day). 5. cinacalcet 30 mg tablet sig: one (1) tablet po daily (daily). 6. metoprolol succinate 25 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po daily (daily). 7. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). 8. aluminum-magnesium hydroxide 225-200 mg/5 ml suspension sig: 15-30 mls po qid (4 times a day) as needed. 9. latanoprost 0.005 % drops sig: one (1) drop ophthalmic hs (at bedtime). 10. dorzolamide-timolol 2-0.5 % drops sig: one (1) drop ophthalmic (2 times a day). 11. apraclonidine 0.5 % drops sig: one (1) drop ophthalmic tid (3 times a day). 12. amiodarone 200 mg tablet sig: one (1) tablet po daily (daily). 13. tacrolimus 0.5 mg capsule sig: one (1) capsule po bid (2 times a day). 14. insulin glargine 100 unit/ml solution sig: forty (40) units subcutaneous at bedtime. 16. humalog 100 unit/ml solution sig: as directed subcutaneous four times a day. 19. warfarin 1 mg tablet sig: three (3) tablet po daily (daily). 20. quetiapine 25 mg tablet sig: one (1) tablet po hs prn () as needed for agitation. 21. acetaminophen 325 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed. 22. insulin glargine 100 unit/ml solution sig: as directed subcutaneous at bedtime: 40 units. 23. humalog 100 unit/ml solution sig: as directed subcutaneous four times a day: ac scale: glucoses <120 / no insulin glucoses 121-160/10u glucoses 161-200/12u glucoses 201-240/14u glucoses 241-280/16u glucoses 281-320/18u glucoses 321-360/20u glucoses > 320 md : glucoses < 200 no insulin glucoses 201-240/2u glucoses 241-280/4u glucoses 281-320/6u glucoses 321-360/8u glucoses >360 md. discharge disposition: extended care facility: - discharge diagnosis: aortic stensois by echo chronic unstable infected rt. ankle joint postop ventricular tacycardia with hypotnesion requiring vassopressor and inotropic support, converted to nsr with amidarone and lidocaine history of pvd histroy of htn history of dm2 with neuropathy history of esrd ,s/p cadveric renal transplant history of coronary artery disease with,s/p cabg's discharge condition: stable discharge instructions: weigh yourself every morning, md if weight > 3 lbs. adhere to 2 gm sodium diet fluid restriction: sbe prophlaxsis for dental procedure or invasive tests no stump shrinkers followup instructions: 3-4 weeks dr. . call for appointment md procedure: diagnostic ultrasound of heart other amputation below knee diagnoses: other iatrogenic hypotension nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere cardiac complications, not elsewhere classified atrial fibrillation aortic valve disorders diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes paroxysmal ventricular tachycardia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy kidney replaced by transplant other bone involvement in diseases classified elsewhere chronic osteomyelitis, ankle and foot 

Answer: The patient is high likely exposed to